Combined Antiplatelet Therapy Reduces the Proinflammatory Properties of Activated Platelets
The cause of atherothrombosis is rupture or erosion of atherosclerotic lesions, leading to an increased risk of myocardial infarction or stroke. Here, platelet activation plays a major role, leading to the release of bioactive molecules, for example, chemokines and coagulation factors, and to platel...
Main Authors: | Alexandra C.A. Heinzmann, Daniëlle M. Coenen, Tanja Vajen, Judith M.E.M. Cosemans, Rory R. Koenen |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2021-10-01
|
Series: | TH Open |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-1682-3415 |
Similar Items
-
Antiplatelet agents: an overview
by: Asma Haffouz, et al.
Published: (2023-01-01) -
Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
by: Nadji Hannachi, et al.
Published: (2020-06-01) -
Rapid Internalization and Nuclear Translocation of CCL5 and CXCL4 in Endothelial Cells
by: Annemiek Dickhout, et al.
Published: (2021-07-01) -
Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
by: Deok Hee Lee, et al.
Published: (2012-02-01) -
Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
by: Anne Godier, et al.
Published: (2020-07-01)